Cytokine profiling reveals increased serum inflammatory cytokines in idiopathic choroidal neovascularization
Authors:
Open Access
- 24 April 2019
- journal article
- research article
- Published by Springer Nature in BMC Ophthalmology
- Vol. 19 (1) , 1-5
Abstract
The exact pathogenesis of idiopathic choroidal neovascularization (ICNV) remains unclear. Cytokine-mediated inflammation has been thought to be involved in the pathophysiology of ICNV. The purpose of this study was to investigate serum cytokine profiles in patients with ICNV and to explore the relationship between serum cytokine levels and ICNV severity. This case-control study was conducted in 32 ICNV patients and 30 healthy volunteers. Clinical and demographic information was obtained from the medical data platform and the serum was analysed with a multiplex assay to determine the levels of seven cytokines: interleukin (IL)-2, IL-10, IL-15, IL-17, basic fibroblast growth factor (basic FGF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and vascular endothelial growth factor (VEGF). Serum levels of IL-2, IL-10, IL-17, basic FGF, and VEGF were elevated in ICNV patients compared to controls. Serum GM-CSF levels were positively related to central retinal thickness, and serum IL-17 levels were positively related to CNV lesion area. Serum inflammatory cytokines were significantly elevated in ICNV patients compared to controls. This suggests that systemic inflammation may play a critical role in the physiopathology of ICNV.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (81571819, 81500766)
- Natural Science Foundation of Zhejiang Province (LQ19H120011)
- Program of Zhejiang Medical Technology (2019328715)
This publication has 35 references indexed in Scilit:
- Angiopoietin-like Protein 2 Is a Multistep Regulator of Inflammatory Neovascularization in a Murine Model of Age-related Macular DegenerationJournal of Biological Chemistry, 2016
- The Role of LOX and LOXL2 in the Pathogenesis of an Experimental Model of Choroidal NeovascularizationInvestigative Ophthalmology & Visual Science, 2015
- SUBFOVEAL CHOROIDAL THICKNESS IN IDIOPATHIC CHOROIDAL NEOVASCULARIZATION AND TREATMENT OUTCOMES AFTER INTRAVITREAL BEVACIZUMAB THERAPYRetina, 2015
- Subfoveal Choroidal Thickness in Idiopathic Choroidal NeovascularizationOphthalmology, 2014
- JNK inhibition reduces apoptosis and neovascularization in a murine model of age-related macular degenerationProceedings of the National Academy of Sciences, 2013
- Intravitreal Bevacizumab for Treatment of Subfoveal Idiopathic Choroidal Neovascularization: Results of a 1-Year Prospective TrialAmerican Journal of Ophthalmology, 2012
- High-Mobility Group Box-1 Mediates Toll-Like Receptor 4–Dependent AngiogenesisArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Intravitreal Bevacizumab for Subfoveal Idiopathic Choroidal NeovascularizationArchives of Ophthalmology (1950), 2007
- The prognosis of idiopathic choroidal neovascularization in persons younger than 50 years of ageOphthalmology, 1998
- The Natural History of Idiopathic Subfoveal Choroidal NeovascularizationOphthalmology, 1995